CY1124481T1 - Σταθερα χωρις συντηρητικα μυδριατικα και αντιοξειδωτικα διαλυματα για εγχυση - Google Patents
Σταθερα χωρις συντηρητικα μυδριατικα και αντιοξειδωτικα διαλυματα για εγχυσηInfo
- Publication number
- CY1124481T1 CY1124481T1 CY20211100633T CY211100633T CY1124481T1 CY 1124481 T1 CY1124481 T1 CY 1124481T1 CY 20211100633 T CY20211100633 T CY 20211100633T CY 211100633 T CY211100633 T CY 211100633T CY 1124481 T1 CY1124481 T1 CY 1124481T1
- Authority
- CY
- Cyprus
- Prior art keywords
- injection
- solid
- preservatives agents
- antioxidant solutions
- antioxidant
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title 1
- 230000003078 antioxidant effect Effects 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 239000003755 preservative agent Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 239000000243 solution Substances 0.000 title 1
- 238000001802 infusion Methods 0.000 abstract 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 abstract 1
- 229960004752 ketorolac Drugs 0.000 abstract 1
- 239000012669 liquid formulation Substances 0.000 abstract 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 abstract 1
- 229960001802 phenylephrine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/08—Mydriatics or cycloplegics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Surgery (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261718026P | 2012-10-24 | 2012-10-24 | |
| US201261736179P | 2012-12-12 | 2012-12-12 | |
| PCT/US2013/066349 WO2014066485A1 (en) | 2012-10-24 | 2013-10-23 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124481T1 true CY1124481T1 (el) | 2022-07-22 |
Family
ID=50545210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100633T CY1124481T1 (el) | 2012-10-24 | 2021-07-13 | Σταθερα χωρις συντηρητικα μυδριατικα και αντιοξειδωτικα διαλυματα για εγχυση |
Country Status (39)
| Country | Link |
|---|---|
| US (6) | US9066856B2 (h) |
| EP (2) | EP3909572B1 (h) |
| JP (8) | JP6017053B2 (h) |
| KR (4) | KR20170128640A (h) |
| CN (2) | CN104822265A (h) |
| AP (1) | AP2015008459A0 (h) |
| AR (1) | AR093115A1 (h) |
| AU (1) | AU2013201465B2 (h) |
| BR (1) | BR112015009228B1 (h) |
| CA (1) | CA2887772C (h) |
| CL (1) | CL2015001078A1 (h) |
| CR (1) | CR20150233A (h) |
| CU (1) | CU20150037A7 (h) |
| CY (1) | CY1124481T1 (h) |
| DK (1) | DK2911511T3 (h) |
| EA (1) | EA033811B1 (h) |
| ES (1) | ES2875432T3 (h) |
| GE (1) | GEP20186891B (h) |
| HR (1) | HRP20210980T1 (h) |
| HU (1) | HUE055537T2 (h) |
| IL (1) | IL238439B2 (h) |
| IN (1) | IN2015DN03029A (h) |
| LT (1) | LT2911511T (h) |
| MA (1) | MA38096B1 (h) |
| MD (1) | MD20150050A2 (h) |
| MX (2) | MX2020012591A (h) |
| MY (2) | MY204103A (h) |
| NZ (1) | NZ628398A (h) |
| PE (1) | PE20150958A1 (h) |
| PH (1) | PH12015500850B1 (h) |
| PL (1) | PL2911511T3 (h) |
| PT (1) | PT2911511T (h) |
| RS (1) | RS62188B1 (h) |
| SG (1) | SG11201502602WA (h) |
| SI (1) | SI2911511T1 (h) |
| SM (1) | SMT202100393T1 (h) |
| UA (1) | UA114650C2 (h) |
| WO (1) | WO2014066485A1 (h) |
| ZA (1) | ZA201502684B (h) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1684701B (zh) | 2002-07-30 | 2012-10-17 | 奥默罗斯公司 | 眼科冲洗液及方法 |
| AU2013201465B2 (en) * | 2012-10-24 | 2016-03-03 | Rayner Intraocular Lenses Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
| US20210346318A1 (en) * | 2013-10-03 | 2021-11-11 | Harrow Ip, Llc | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| BR112016007328A2 (pt) | 2013-10-03 | 2017-08-01 | Imprimis Pharmaceuticals Inc | composições oftálmicas baseadas em epinefrina para administração intraocular e métodos para fabricar as mesmas |
| TWI809304B (zh) * | 2014-12-01 | 2023-07-21 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
| CN104856990A (zh) * | 2015-05-07 | 2015-08-26 | 武汉武药科技有限公司 | 去氧肾上腺素酮咯酸溶液及制备方法 |
| US11213480B1 (en) | 2015-08-06 | 2022-01-04 | Hikma Pharmaceuticals International Limited | Phenylephrine hydrochloride ready-to-use solution |
| USD831868S1 (en) | 2015-09-17 | 2018-10-23 | Lume Cube, Inc. | Compact external light |
| US10704745B2 (en) | 2015-10-13 | 2020-07-07 | Lume Cube, Inc. | Mobile light source |
| EP3503873A4 (en) | 2016-08-25 | 2020-04-15 | Harrow IP, LLC | EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHOD FOR THE PRODUCTION THEREOF |
| US20180318319A1 (en) * | 2017-05-04 | 2018-11-08 | Ocular Science, Inc. | Compositions and Methods for Treating Eyes and Methods of Preparation |
| JP7078843B2 (ja) * | 2018-03-26 | 2022-06-01 | サミー株式会社 | 遊技機 |
| BR112021007725A2 (pt) * | 2018-10-26 | 2021-07-27 | Ocuphire Pharma, Inc. | métodos e composições para tratamento de presbiopia, midríase e outros distúrbios oculares |
| US11071724B2 (en) | 2019-05-17 | 2021-07-27 | Ocular Science, Inc. | Compositions and methods for treating presbyopia |
| DE102019125430B3 (de) * | 2019-09-20 | 2020-11-19 | Carl Zeiss Meditec Ag | Steuerungsvorrichtung für ein ophthalmochirurgisches System, ophthalmochirurgisches System sowie Computerprogrammprodukt |
| KR102749980B1 (ko) | 2020-01-02 | 2025-01-03 | 삼성전자주식회사 | 에어 스페이서를 가지는 반도체 소자 |
| WO2021150747A1 (en) * | 2020-01-22 | 2021-07-29 | Nevakar Inc. | Phenylephrine hydrochloride compositions and containers |
| WO2022132567A1 (en) * | 2020-12-17 | 2022-06-23 | Harrow Ip, Llc | Mydriatic compositions and methods for fabricating thereof |
| CN115368310B (zh) | 2021-05-18 | 2025-06-27 | 奥库菲尔医药公司 | 合成甲磺酸酚妥拉明的方法 |
| US12029729B2 (en) | 2021-07-23 | 2024-07-09 | Somerset Therapeutics, Llc | Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof |
| US11883382B2 (en) | 2021-07-23 | 2024-01-30 | Somerset Therapeutics, Llc | Buffer-free ophthalmological compositions of ketorolac and phenylephrine and applications thereof |
| WO2024086268A1 (en) * | 2022-10-19 | 2024-04-25 | Fresenius Kabi Austria Gmbh | Phenylephrine liquid formulations |
| CN115950992B (zh) * | 2023-03-15 | 2023-06-09 | 苏州朗易生物医药研究有限公司 | 一种去氧肾上腺素酮咯酸溶液中有关物质的检测方法及其应用 |
| WO2025165753A1 (en) * | 2024-01-31 | 2025-08-07 | Hikma Pharmaceuticals Usa Inc. | Pharmaceutical formulations of phenylephrine and process of making the same |
Family Cites Families (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4402949A (en) | 1979-11-12 | 1983-09-06 | Sandoz Ltd. | Stable solutions of hydrogenated ergotalkaloids |
| US4550022A (en) | 1981-10-05 | 1985-10-29 | Alcon Laboratories, Inc. | Tissue irrigating solution |
| JPS58126810A (ja) | 1981-12-24 | 1983-07-28 | Kaken Pharmaceut Co Ltd | 抗炎症眼科用液剤およびその製法 |
| US4474751A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
| JPS6017053U (ja) | 1983-07-11 | 1985-02-05 | 住友電気工業株式会社 | 伝送エラ−検出器 |
| WO1987007141A1 (en) | 1986-05-23 | 1987-12-03 | New England Medical Center Hospitals, Inc. | Method for treating glaucoma |
| US5212196A (en) | 1986-10-21 | 1993-05-18 | Alcon Laboratories, Inc. | Control of post-surgical intraocular pressure using clonidine derivatives |
| US4938970A (en) | 1987-02-06 | 1990-07-03 | Hustead Robert E | Painless electrolyte solutions |
| US5110493A (en) | 1987-09-11 | 1992-05-05 | Syntex (U.S.A.) Inc. | Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant |
| US4876250A (en) | 1988-10-31 | 1989-10-24 | Alcon Laboratories, Inc. | Methods for controlling ocular hypertension with angiostatic steroids |
| DE3833893A1 (de) | 1988-10-05 | 1990-04-12 | Bayer Ag | Verwendung von basischen nitro-phenyl-dihydropyridin-amiden als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung ueber neue zwischenprodukte |
| US5051443A (en) | 1988-10-12 | 1991-09-24 | Eye Research Institute Of Retina Foundation, Inc. | Method for enhancing healing of corneal endothelial wounds |
| US5036046A (en) | 1988-10-12 | 1991-07-30 | Eye Research Institute Of Retina Foundation, Inc. | Method for enhancing healing of corneal endothelial wounds |
| US5371078A (en) | 1988-10-31 | 1994-12-06 | Alcon Laboratories, Inc. | Angiostatic steroids and methods and compositions for controlling ocular hypertension |
| US5116868A (en) | 1989-05-03 | 1992-05-26 | The Johns Hopkins University | Effective ophthalmic irrigation solution |
| CA2065375A1 (en) | 1989-08-21 | 1991-02-22 | Richard J. Sharpe | Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists |
| US5679650A (en) * | 1993-11-24 | 1997-10-21 | Fukunaga; Atsuo F. | Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine |
| DE69114470T2 (de) | 1990-09-07 | 1996-07-18 | Univ Alicante | Komposition für die behandlung von augenschmerzen. |
| US5318780A (en) | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
| IT1252692B (it) | 1991-11-27 | 1995-06-23 | Zambon Spa | Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi |
| CA2126093A1 (en) | 1992-10-21 | 1994-04-28 | Owen Gan | Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
| US6117907A (en) | 1993-04-14 | 2000-09-12 | Sher; Neal A. | Topical treatment of ocular pain after corneal surgery |
| CA2149657A1 (en) | 1993-09-29 | 1995-04-06 | Billie M. York | Compositions containing growth factors and antiplastic agents |
| AU7846794A (en) | 1993-09-29 | 1995-04-18 | Alcon Laboratories, Inc. | Compositions containing growth factors and antimetabolites |
| US5624893A (en) | 1993-10-14 | 1997-04-29 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation |
| JPH09506620A (ja) | 1993-12-17 | 1997-06-30 | アルコン・ラボラトリーズ，インコーポレイテッド | 非ステロイド抗炎症剤を含有する改良された眼内洗浄溶液 |
| US6350781B1 (en) | 1994-01-14 | 2002-02-26 | Lee Shahinia, Jr. | Method and analgesic preparations for sustained and extended corneal analgesia with subanesthetic concentrations of lidocaine |
| WO1995034298A1 (en) | 1994-06-10 | 1995-12-21 | Telor Ophthalmic Pharmaceuticals, Inc. | Inhibition of intraoperative miosis/production of mydriasis by local anesthetics |
| US5523316A (en) | 1994-06-23 | 1996-06-04 | Alcon Laboratories, Inc. | Intraocular irrigating solution containing agent for controlling IOP |
| US6492332B1 (en) | 1995-12-12 | 2002-12-10 | Omeros Corporation | Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation |
| KR100517210B1 (ko) | 1994-12-12 | 2006-06-07 | 오메로스 코포레이션 | 통증,염증및경련억제용관주용액 |
| WO2000023061A2 (en) | 1998-10-21 | 2000-04-27 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
| US7091181B2 (en) | 1994-12-12 | 2006-08-15 | Omeros Corporation | Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors |
| WO2000023072A1 (en) | 1998-10-20 | 2000-04-27 | Omeros Medical Systems, Inc. | Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation |
| RU2180852C2 (ru) | 1994-12-12 | 2002-03-27 | Омерос Медикл Системс, Инк. | Ингибирующий раствор и способ подавления боли, воспаления или спазма |
| JPH10510540A (ja) | 1994-12-12 | 1998-10-13 | オメロス メディカル システムズ，インコーポレーテッド | 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法 |
| US5972326A (en) | 1995-04-18 | 1999-10-26 | Galin; Miles A. | Controlled release of pharmaceuticals in the anterior chamber of the eye |
| US5612027A (en) | 1995-04-18 | 1997-03-18 | Galin; Miles A. | Controlled release of miotic and mydriatic drugs in the anterior chamber |
| US5767105A (en) | 1995-05-03 | 1998-06-16 | Peyman; Gholam A. | Ocular solution |
| US5798356A (en) | 1995-08-07 | 1998-08-25 | Alcon Laboratories, Inc. | Angiostatic compounds |
| US5849761A (en) | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
| US6413961B1 (en) | 1995-12-12 | 2002-07-02 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
| US6280745B1 (en) | 1997-12-23 | 2001-08-28 | Alliance Pharmaceutical Corp. | Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| EP1039818A4 (en) | 1996-07-26 | 2001-11-07 | Schein Dental Equipment Co | ARMREST MECHANISM FOR DENTAL ARMCHAIRS |
| GB9704352D0 (en) | 1997-03-03 | 1997-04-23 | Chiroscience Ltd | Levobupivacaine and its use |
| AU6883798A (en) | 1997-04-02 | 1998-10-22 | Regents Of The University Of California, The | Method of anesthesia |
| US5811446A (en) | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| US6034256A (en) | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
| US6495598B1 (en) | 1997-04-22 | 2002-12-17 | Ophtecs Corporation | Perfusate preparation for ophthalmic operation |
| EP0903151A1 (en) | 1997-09-22 | 1999-03-24 | ASTA Medica Aktiengesellschaft | Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| DE69928806T2 (de) | 1998-07-01 | 2006-07-20 | Warner-Lambert Co. Llc | (-)-pseudoephedrin als sympathomimetisches arzneimittel |
| ATE203668T1 (de) | 1998-07-14 | 2001-08-15 | Alcon Lab Inc | Verwendung von 11-(3-dimethylaminopropyliden)-6, 11-dihydrodibenz(b,e)oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation |
| US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| FR2782721B1 (fr) | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | Nouveaux composes phosphohalohydrines, procede de fabrication et applications |
| US6395746B1 (en) | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
| EP1434573A2 (en) | 1998-10-20 | 2004-07-07 | Omeros Corporation | Irrigation solution and method for inhibition of pain and inflammation |
| US20030087962A1 (en) | 1998-10-20 | 2003-05-08 | Omeros Corporation | Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
| AU1319200A (en) | 1998-10-20 | 2000-05-08 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
| US7973068B2 (en) | 1998-10-20 | 2011-07-05 | Omeros Corporation | Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
| EP1206275B1 (en) | 1998-11-05 | 2007-09-05 | Omeros Corporation | Irrigation solution and method for inhibition of pain and inflammation |
| WO2000035433A2 (en) | 1998-12-17 | 2000-06-22 | Alcon Laboratories, Inc. | Methods for the prevention and treatment of post-surgical complications |
| KR20010108296A (ko) * | 1999-03-02 | 2001-12-07 | 출원후보충 | 눈의 질병을 치료 또는 예방하기 위한 유리체내 투여용 약제 |
| CN1353573A (zh) | 1999-05-14 | 2002-06-12 | 加利福尼亚大学董事会 | 对炎症介导感染的抗炎症治疗 |
| AU5286901A (en) | 1999-10-22 | 2001-06-18 | Transdermatech, Inc. | Topical anesthetic formulation |
| US6218428B1 (en) | 2000-04-28 | 2001-04-17 | Emil Chynn | Ophthalmic composition |
| JP2004512260A (ja) | 2000-04-28 | 2004-04-22 | メモリアル スローン−ケッタリング キャンサー センター | 局所麻酔／オピオイド製剤およびその使用方法 |
| US20020128267A1 (en) | 2000-07-13 | 2002-09-12 | Rebanta Bandyopadhyay | Method of using COX-2 inhibitors in the treatment and prevention of ocular COX-2 mediated disorders |
| PE20020146A1 (es) | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
| JP2004503593A (ja) | 2000-07-14 | 2004-02-05 | アラーガン、インコーポレイテッド | 増大した溶解度を持つ治療活性成分を含む組成物 |
| JP2004518612A (ja) | 2000-07-28 | 2004-06-24 | インスパイアー ファーマシューティカルズ，インコーポレイティド | インドール誘導体を用いて眼圧を下降させる方法 |
| JP2002161032A (ja) | 2000-09-14 | 2002-06-04 | Taisho Pharmaceut Co Ltd | 粘膜適用組成物 |
| WO2002024191A1 (fr) | 2000-09-20 | 2002-03-28 | Yong Guang Pharmaceutical Co., Ltd. | Medicament permettant de traiter et de prevenir la myopie |
| US20020183279A1 (en) | 2001-04-18 | 2002-12-05 | Koichiro Tanaka | Pharmaceutical composition containing viscoelastic substance and medication |
| US20020198209A1 (en) | 2001-05-03 | 2002-12-26 | Allergan Sales Inc. | Compositions having enhanced pharmacokinetic characteristics |
| US20030191187A1 (en) | 2002-04-01 | 2003-10-09 | Lee Fang Yu | Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same |
| CN1684701B (zh) * | 2002-07-30 | 2012-10-17 | 奥默罗斯公司 | 眼科冲洗液及方法 |
| US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| WO2006069213A1 (en) * | 2004-12-22 | 2006-06-29 | Schering Corporation | Pharmaceutical formulations |
| CN101083984B (zh) | 2004-12-23 | 2010-11-10 | 罗克斯罗制药公司 | 用于经鼻内投与酮咯酸（ketorolac）的治疗组合物 |
| FR2882930B1 (fr) | 2005-03-09 | 2009-03-27 | Walid Katib | Nouvelles compositions ophtalmologiques et leur mode d'utilisation |
| DOP2007000055A (es) * | 2006-04-10 | 2007-10-31 | Senosiain S A De C V Lab | Composición farmaceutica que comprende un analgésico y vitaminas |
| US20090258850A1 (en) | 2007-08-21 | 2009-10-15 | Frincke James M | Stabilized therapeutic compositions and formulations |
| JP2011503061A (ja) | 2007-11-08 | 2011-01-27 | アーシエックス セラピューティックス， インコーポレイテッド | 浸透圧活性剤及び血管収縮剤を含む眼けん腫脹の治療及び防止のための組成物 |
| WO2009074853A2 (en) | 2007-12-10 | 2009-06-18 | Promed Research Centre | Ophthalmic composition comprising phenylephrine |
| US7842714B2 (en) | 2008-03-03 | 2010-11-30 | Allergan, Inc. | Ketorolac tromethamine compositions for treating ocular pain |
| US9192571B2 (en) | 2008-03-03 | 2015-11-24 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
| MX2011009312A (es) * | 2009-03-06 | 2012-02-29 | Medimmune Llc | Formulaciones de anticuerpos humanizados anti-cd19. |
| US8277781B2 (en) | 2009-03-13 | 2012-10-02 | Luitpold Pharmaceuticals, Inc. | Device for intranasal administration |
| MX2011013061A (es) * | 2009-06-05 | 2012-02-28 | Aciex Therapeutics Inc | Formulaciones oftalmicas de fluticasona y metodos de uso. |
| JP2012528888A (ja) | 2009-06-05 | 2012-11-15 | アーシエックス セラピューティックス， インコーポレイテッド | 眼科用配合剤、その製造方法およびその使用方法 |
| US8680510B2 (en) | 2010-06-28 | 2014-03-25 | International Business Machines Corporation | Method of forming compound semiconductor |
| TR201818754T4 (tr) | 2010-07-29 | 2019-01-21 | Allergan Inc | Koruyucu içermeyen Brimonidin Ve Timolol Çözeltileri |
| AU2013201465B2 (en) * | 2012-10-24 | 2016-03-03 | Rayner Intraocular Lenses Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
| TWI809304B (zh) | 2014-12-01 | 2023-07-21 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
-
2013
- 2013-03-07 AU AU2013201465A patent/AU2013201465B2/en active Active
- 2013-10-23 IL IL238439A patent/IL238439B2/en unknown
- 2013-10-23 CN CN201380055290.3A patent/CN104822265A/zh active Pending
- 2013-10-23 MY MYPI2020001054A patent/MY204103A/en unknown
- 2013-10-23 MX MX2020012591A patent/MX2020012591A/es unknown
- 2013-10-23 MA MA38096A patent/MA38096B1/fr unknown
- 2013-10-23 US US14/061,039 patent/US9066856B2/en active Active
- 2013-10-23 PE PE2015000544A patent/PE20150958A1/es unknown
- 2013-10-23 CN CN201810548093.XA patent/CN108721210A/zh active Pending
- 2013-10-23 EP EP21167904.8A patent/EP3909572B1/en active Active
- 2013-10-23 ES ES13848382T patent/ES2875432T3/es active Active
- 2013-10-23 SM SM20210393T patent/SMT202100393T1/it unknown
- 2013-10-23 BR BR112015009228-4A patent/BR112015009228B1/pt active IP Right Grant
- 2013-10-23 SI SI201331903T patent/SI2911511T1/sl unknown
- 2013-10-23 MY MYPI2015001038A patent/MY188474A/en unknown
- 2013-10-23 JP JP2015539749A patent/JP6017053B2/ja active Active
- 2013-10-23 IN IN3029DEN2015 patent/IN2015DN03029A/en unknown
- 2013-10-23 AR ARP130103855A patent/AR093115A1/es not_active Application Discontinuation
- 2013-10-23 HR HRP20210980TT patent/HRP20210980T1/hr unknown
- 2013-10-23 MD MDA20150050A patent/MD20150050A2/ro not_active Application Discontinuation
- 2013-10-23 SG SG11201502602WA patent/SG11201502602WA/en unknown
- 2013-10-23 EA EA201590807A patent/EA033811B1/ru unknown
- 2013-10-23 MX MX2015005089A patent/MX382411B/es unknown
- 2013-10-23 KR KR1020177033129A patent/KR20170128640A/ko not_active Ceased
- 2013-10-23 EP EP13848382.1A patent/EP2911511B1/en active Active
- 2013-10-23 RS RS20210878A patent/RS62188B1/sr unknown
- 2013-10-23 NZ NZ628398A patent/NZ628398A/en unknown
- 2013-10-23 CA CA2887772A patent/CA2887772C/en active Active
- 2013-10-23 AP AP2015008459A patent/AP2015008459A0/xx unknown
- 2013-10-23 GE GEAP201313833A patent/GEP20186891B/en unknown
- 2013-10-23 UA UAA201505028A patent/UA114650C2/uk unknown
- 2013-10-23 PL PL13848382T patent/PL2911511T3/pl unknown
- 2013-10-23 HU HUE13848382A patent/HUE055537T2/hu unknown
- 2013-10-23 LT LTEP13848382.1T patent/LT2911511T/lt unknown
- 2013-10-23 DK DK13848382.1T patent/DK2911511T3/da active
- 2013-10-23 KR KR1020217002992A patent/KR102496463B1/ko active Active
- 2013-10-23 PT PT138483821T patent/PT2911511T/pt unknown
- 2013-10-23 WO PCT/US2013/066349 patent/WO2014066485A1/en active Application Filing
- 2013-10-23 KR KR1020197038220A patent/KR102211784B1/ko active Active
- 2013-10-23 KR KR1020157012282A patent/KR101808394B1/ko active Active
-
2015
- 2015-04-17 PH PH12015500850A patent/PH12015500850B1/en unknown
- 2015-04-21 ZA ZA2015/02684A patent/ZA201502684B/en unknown
- 2015-04-21 CU CUP2015000037A patent/CU20150037A7/es unknown
- 2015-04-24 CL CL2015001078A patent/CL2015001078A1/es unknown
- 2015-05-06 CR CR20150233A patent/CR20150233A/es unknown
- 2015-05-26 US US14/721,151 patent/US9486406B2/en active Active
-
2016
- 2016-08-24 JP JP2016163544A patent/JP6282699B2/ja active Active
- 2016-09-28 US US15/278,514 patent/US9855246B2/en active Active
- 2016-10-24 JP JP2016208082A patent/JP2017014294A/ja active Pending
-
2017
- 2017-11-27 US US15/823,282 patent/US20180085349A1/en not_active Abandoned
-
2018
- 2018-01-11 JP JP2018002514A patent/JP2018058905A/ja not_active Withdrawn
-
2019
- 2019-02-28 JP JP2019036146A patent/JP2019081798A/ja not_active Withdrawn
-
2020
- 2020-06-17 JP JP2020104619A patent/JP2020147606A/ja not_active Withdrawn
-
2021
- 2021-07-13 CY CY20211100633T patent/CY1124481T1/el unknown
- 2021-12-16 US US17/552,872 patent/US12133842B2/en active Active
-
2023
- 2023-01-31 JP JP2023012804A patent/JP2023041804A/ja not_active Withdrawn
-
2024
- 2024-10-10 US US18/912,202 patent/US20250032452A1/en active Pending
- 2024-11-29 JP JP2024207997A patent/JP2025019330A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124481T1 (el) | Σταθερα χωρις συντηρητικα μυδριατικα και αντιοξειδωτικα διαλυματα για εγχυση | |
| CY1124431T1 (el) | Συριγγα | |
| CY1121928T1 (el) | Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης | |
| JOP20180102B1 (ar) | مركب صيدلاني | |
| CY1122796T1 (el) | Βελτιωμενες φαρμακοτεχνικες μορφες αδενοϊων | |
| CY1123490T1 (el) | Συνθεσεις που προερχονται απο χιτοζανη | |
| CY1118680T1 (el) | Φαρμακευτικη συνθεση | |
| EA201591748A1 (ru) | Модуляторы p2x7 | |
| EA201490420A1 (ru) | ЛЕЧЕНИЕ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С α-СУБЪЕДИНИЦАМИ ПОТЕНЦИАЛЗАВИСИМЫХ НАТРИЕВЫХ КАНАЛОВ (SCNxA), С ПОМОЩЬЮ МАЛЫХ МОЛЕКУЛ | |
| UA114087C2 (xx) | Похідні піридину | |
| EA201690780A1 (ru) | Пегилированные лекарственные средства-линкеры для улучшенной фармакокинетики конъюгатов лиганд-лекарственное средство | |
| NI201400083A (es) | Compuesto de imidazopirrolidinona | |
| MX380701B (es) | Transporte para atravesar la barrera hematoencefalica. | |
| TR201816986T4 (tr) | Terapötik ajan iletim formülasyonlarına yönelik lipitler. | |
| EA201300146A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ МОДУЛЯТОРА c-МЕТ | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| JOP20140114B1 (ar) | مركبات حلقية غير متجانسة واستخداماتها | |
| EA201590887A1 (ru) | Композиция | |
| BR112014025041B8 (pt) | Composição farmacêutica | |
| EA201590805A1 (ru) | Композиция с немедленным и пролонгированным высвобождением | |
| CO6920289A2 (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib. | |
| MX2014001368A (es) | Soluciones anti-inflamatorias estables para inyección. | |
| MX384131B (es) | Compuestos neurotransmisores de dihidroxifenilo, composiciones y métodos. | |
| EA201591717A1 (ru) | Твердые формы гидрохлорида вемурафениба | |
| CY1118277T1 (el) | Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης |